Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors

Molecular Carcinogenesis

Volumn 49, Issue 9, 2010, Pages 818-825

  Malakootian, Mahshid ^a   Mowla, Seyed Javad ^a   Saberi, Hooshang ^b,c   Asadi, Malek Hossein ^a   Atlasi, Yaser ^a   Shafaroudi, Afsaneh Malekzadeh ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brain tumors; Cancer stem cell; Gene expression; Nucleostemin; Self renewal; Spliced variant

Indexed keywords

NUCLEOSTEMIN; TUMOR MARKER; UNCLASSIFIED DRUG; PROTEIN; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; BRAIN TUMOR; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; CHILD; CHORDOMA; CRANIOPHARYNGIOMA; EWING SARCOMA; FEMALE; FLOW CYTOMETRY; GENETIC VARIABILITY; GLIOBLASTOMA; GLIOMA; HEMANGIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; NEURILEMOMA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SPLICING; SCHOOL CHILD; BRAIN; CELL CYCLE; CELL LINE; CELL PROLIFERATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STEM CELL;

ADULT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; MIDDLE AGED; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SPLICING; RNA, SMALL INTERFERING; STEM CELLS;

EID: 77956214722     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20658     Document Type: Article

References (31)

1. Reya T, Morrison SJ, Clarke MF, Weissman I. Stem cells, cancer, and cancer stem cells. Nature 2001;414:104-111.
2. Al-hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004;23:7274-7282.
3. Soltysova A, Altanerova V, Altaner C. Cancer stem cells. Neoplasma 2005;52:435-440.
4. Tsai RYL. A molecular view of stem cell and cancer cell self-renewal. Int J Biochem Cell Biol 2004;36:684-694. (Pubitemid 38316823)
5. Zhang M, Rosen JM. Stem cells in the etiology and treatment of cancer. Curr Opin Genet Dev 2006;16:60-64.
6. Molofsky AV, Pardal R, Morrison SJ. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 2004;16:700-707.
7. Bernardi R, Pandolfi P. The nucleolus: At the stem of immortality. Nat Med 2003;9:24-25.
8. Tsai RYL, Mckay RDG. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002;16:2991-3003. (Pubitemid 35424188)
9. Yaghoobi MM, Mowla SJ, Tiraihi T. Nucleostemin, a coordinator of self-renewal, is expressed in rat marrow stromal cells and turns off after induction of neural differentiation. Neurosci Lett 2005:1-6.
10. Liu SJ, Cai ZW, Liu YJ, et al. Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies. World J Gastroenterol 2004;10:1246-1249.
11. Sijin L, Ziwei C, Yajun L, et al. The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of hela cells. J Exp Clin Cancer Res 2004;23:529-538.
12. Kleihues P, Cavanee WK. Pathology and genetics tumors of the nervous system. Lyon: IARC Press; 2000.
13. Deangelis LM. Brain tumors. N Engl J Med 2001;344:114-123.
14. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007;120:1598-1602. (Pubitemid 46355399)
15. Jafari Kermani A, Fathi F, Mowla SJ. Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: Potential application in cell-based gene therapy. Rejuvenation Res 2008;11:
16. American Cancer Society. http://www.cancer.org.
17. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-5828.
18. Oliver TG, Wechsler-Reya RJ. Getting at the root and stem of brain tumors. Neuron 2004;42:885-888. (Pubitemid 38798227)
19. Sanai N, Alvarez B, Berger MS. Mechanisms of disease neural stem cells and the origin of gliomas. N Engl J Med 2005;353:811-822.
20. Fomchenko EI, Holland EC. Stem cells and brain cancer. Exp Cell Res 2005;306:323-329.
21. Galderisi U, Cipollaro M, Giordano A. Stem cells and brain cancer. Cell Death Differ 2006;13:5-11.
22. Kondo T. Brain cancer stem-like cells. Eur J Cancer 2006;42:1237-1242.
23. Ehtesham M, Stevenson CB, Thompson RC. Stem cell therapies for malignant glioma. Neurosurg Focus 2005;19:1-11.
24. Kafienah W, Mistry S, Williams C, Hollander AP. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. Stem Cells 2006;24:1113-1120.
25. Fan Y, Liu Z, Zhao S, et al. Nucleostemin mRNAis expressed in both normal and malignant renal tissues. Br J Cancer 2006:1-5.
26. Beekman C, Nichane M, De Clercq S, et al. Evolutionarily conserved role of nucleostemin: Controlling proliferation of stem/progenitor cells during early vertebrate development. Mol Cell Biol 2006;26:9291-9301.
27. Zhu Q, Yasumoto H, Tsai RY. Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol 2006;26:9279-9290. (Pubitemid 44904423)
28. Jafarnejad SM, Mowla SJ, Matin MM. Knocking-down the expression of nucleostemin significantly decreases rate of proliferation of rat bone marrow stromal stem cells in an apparently p53-independent manner. Cell Prolif 2008;41:28-35.
29. Dai MS, Sun XX, Lu H. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol 2008;28:4365-4376.
30. Ma H, Pederson T. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway. Mol Biol Cell 2007;18:2630-2635.
31. Nikpour P, Mowla SJ, Jafarnejad SM, Fischer U, Schulz WA. Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710. Cell Prolif 2009;42:762-769.